Antithrombotic agents, β-blockers, angiotensin-converting enzyme inhibitor or angiotensin II receptor blockers, Mineralocorticoid receptor antagonist and statins should be given to all patients with acute myocardial infarction, exclusion of contraindications. This evidence concerns the gene NR3C2 and myocardial infarction.